Comparison

SkQ1 vs C60 Fullerene

Targeted mitochondrial antioxidant (SkQ1) vs. broad-spectrum radical sponge (C60 fullerene).

Effectiveness Profile

SkQ1
C60 Fullerene

At a Glance

 SkQ1C60 Fullerene
TypeLongevityLongevity
Legal statusResearchResearch
Half-lifeNot formally characterized in humans; mitochondrial residence is prolonged via membrane-potential trapping, supporting once-daily dosing~7 hours (plasma, oral olive-oil vehicle)
Preferred routeOralOral
Dose frequencyonce-dailyonce-daily
Beginner dose125–250 mcg4–8 mg
Intermediate dose250–250 mcg10–15 mg
Advanced dose250–500 mcg20–35 mg
Cycle length12–52 wks4–52 wks
Active duration24h
StorageCapsules: room temperature, dry, protected from light. Visomitin drops: 2–8°C refrigerated, room temperature once opened (use within 30 days).Room temperature in amber glass, away from light; refrigerate after opening
PCT requiredNoNo
Ancillaries requiredNoNo
Safe for womenYesYes

Verdict

SkQ1 wins for:

  • Precision mitochondrial targeting: SkQ1's triphenylphosphonium (TPP+) carrier drives it inside mitochondria, interrupting cardiolipin peroxidation at the source, with orders-of-magnitude higher intramitochondrial concentrations versus generic antioxidants.
  • Clinical validation: Only mito-antioxidant with phase 3 RCT data (Visomitin) and clean animal lifespan extension record across multiple species.
  • Predictable low dosing: Nanomolar-range protocols (100–500 µg/day); bell-shaped dose-response curve is well-mapped.

C60 Fullerene wins for:

  • Raw free-radical scavenging capacity: Each C60 molecule neutralizes dozens of reactive species without being consumed, acting catalytically in tissues.
  • Broader system-wide effects: Nrf2 pathway activation and upregulation of endogenous antioxidant enzymes (SOD, catalase, glutathione).
  • Greater flexibility: Bulk oral and topical approaches; not limited to mitochondrial antioxidant applications. Sourcing is more widespread, with wide community adoption.
  • Fatigue resistance/recovery in some animal models.

Pick A or B?

Pick SkQ1 if:

  • Targeted mitochondrial membrane protection is the main goal (e.g. supporting tissues exposed to high oxidative load on cycles, supporting cardiac or hepatic recovery, looksmaxxing longevity stacks).
  • Dry-eye management or retinoid-induced eye issues are present (ophthalmic forms, e.g. Visomitin).
  • Stack requires tight control of dosing and a clean, bell-shaped response curve.
  • Preference for a compound with clinical validation, proven safety, and traceable manufacturer.

Pick C60 Fullerene if:

  • Seeking broad-spectrum antioxidant and Nrf2 upregulation effects rather than mitochondrial targeting alone.
  • Hepatoprotection is needed on harsh oral cycles and a broad safety net is valuable.
  • Experimenting with fatigue reduction, recovery support, or general oxidative stress lowering (especially in older or high-volume training protocols).
  • Bulk sourcing, price, or topical protocol flexibility matter more than pinpoint mitochondrial action.
  • Willing to invest in high-purity, solvent-free C60 sourcing (quality tolerance is essential for this compound).

Where to Buy

Swiss Chems

Swiss Chems

Ships from US

Affiliate link — we may earn a commission at no cost to you.

Use code-10%
BIOMOGGING